06.01.2022 TOP MEDICAL NEWS - Video
Overview
Here are Todays Top Medical Stories
SGLT2 inhibitors use tied to lower pneumonia risk in diabetics
Pneumonia is a serious disease likely affecting more diabetic patients at a higher risk of pneumonia and pneumonia mortality. Patients with type 2 diabetes using SGLT2 inhibitors are at a significantly lower risk of pneumonia and pneumonia mortality versus those using DPP4 inhibitors, reveals a recent study published in the Journal of Clinical Endocrinology
Sodium glucose co-transporter 2 inhibitors (SGLT2is) are the latest class of glucose-lowerinf agents that have shown to reduce pneumonia risk in clinical trials. However, not much is known about the real-world effectiveness of SGLT2is on the risk of pneumonia.
For more information check out the full story on the link below:
SGLT2 inhibitors use tied to lower pneumonia risk in diabetics: Study
Exposure of children to electromagnetic fields emitted by mobile devices not associated with sleep disturbances
Exposure to electronic gadgets has been more in the recent decade, kids are more or less addicted to devices like mobile and video games. Gadgets are known to largely affect the health of children.
Overall exposure of preadolescent children to electromagnetic fields emitted by mobile communication devices during the day is not associated with sleep disturbances, according to a study led by the Barcelona Institute for Global Health (ISGlobal), an institution supported by "la Caixa" Foundation. However, the study findings, which have been published in Environmental Research, suggest that there may be an effect on sleep when exposure occurs during the evening.
For more information check out the full story on the link below:
Small amounts of carbon monoxide may help protect vision in diabetes
A hypothesis that carbon monoxide (CO) is known to act as an important vascular paracrine factor and plays a role in blood flow regulation in several tissues.
An ingested liquid that ultimately delivers a small dose of carbon monoxide to the eye appears to target key factors that damage or destroy vision in both type 1 and 2 diabetes, scientists say.
The Medical College of Georgia scientists have early evidence that HBI-002, a low-dose oral compound developed by Hillhurst Biopharmaceuticals and already in early stage trials for sickle cell disease, can safely reduce oxidative stress and inflammation in the retina, both early, major contributors to diabetic retinopathy.
For more information check out the full story on the link below:
Small amounts of carbon monoxide may help protect vision in diabetes
Combined laser treatment effective for ear keloids
Keloids are scars that affects the cosmetic outlook of the patient, they pose a much greater challenge to treat as they are very different to treat compared to a scar.
Treatment of ear keloids with a combination of lasers showed a synergistic effect and was found to be effective, according to results from a recent study. The study was published in the Journal of Cosmetic Dermatology on 10 November 2021.
The study showed that a combination laser treatment yielded an excellent outcome in 88% of treated lesions. There was a slightly higher prevalence of excellent outcome of the group which was treated with a further procedure with Enerjet.
For more information check out the full story on the link below:
Speakers
